To include your compound in the COVID-19 Resource Center, submit it here.

Nightstar, Deciphera, NuCana propose NASDAQ IPOs

Ophthalmic gene therapy company Nightstar Therapeutics Ltd. (London, U.K.) (formerly NightstaRx Ltd.) filed to raise up to $86.3 million on Thursday in an IPO on NASDAQ underwritten by Jefferies, Leerink, BMO Capital Markets, Wedbush and Chardan.

The company was spun out of

Read the full 419 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers